Camostat
Camostat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target trypsin-1, transmembrane protease serine 2, and prostasin.
| Trade Name | |
|---|---|
| Common Name | Camostat |
| ChEMBL ID | CHEMBL590799 |
| Indication | |
| Drug Class | Enzyme inhibitors: proteolytic enzyme inhibitors |
